BDMS

Photo: Vyacheslav Argenberg / Wikimedia Commons, CC BY 4.0

BDMS takes majority control of Thai CAR-T developer Genepeutic Bio in $5.1 million share deal

Thailand's largest private hospital operator is lifting its stake in the Ramathibodi Hospital spin-out from 19.9% to 55% as it prepares to offer a locally made CAR-T therapy that it says could cost up to a third less than imported treatments.